Better management strategies are needed for patients with comorbid end-stage COPD and afib.
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
Researchers assessed the clinical outcomes of patients with comorbid heart failure and diabetes receiving treatment with metformin and sulfonylurea.
Investigators examined how genetic factors associated with cardiovascular and non-cardiovascular diseases may have an effect on reported comorbid conditions.
People with pulmonary arterial hypertension display higher levels of depression and anxiety than previously estimated by healthcare workers.
Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.
The risk of sudden cardiac death was present across all strata of left ventricular ejection fraction and was related to the use of cocaine, lower use of beta-blockers, lower CD4, and nonsuppressed viral load.
Further studies are needed to understand the effect of smoking cessation on outcomes in patients undergoing transcatheter aortic valve replacement.
The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.
Inhaled epoprostenol delivered via high-flow nasal cannula increased oxygenation among patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction.